Drug-induced Adverse Events
How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?
Support Care Cancer. 2022 Dec 16;31(1):37. doi: 10.1007/s00520-022-07484-7.
NO ABSTRACT
PMID:36525100 | DOI:10.1007/s00520-022-07484-7
Amoxicillin overdose in the pediatric emergency department: A descriptive study
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Borderline indications for ovarian suppression: addressing uncertainties with patients
Future Oncol. 2022 Dec 15. doi: 10.2217/fon-2022-0478. Online ahead of print.
NO ABSTRACT
PMID:36519535 | DOI:10.2217/fon-2022-0478
From trial to practice: incidence and severity of COVID-19 vaccine side effects in a medically at-risk and vaccine-hesitant community
BMC Public Health. 2022 Dec 14;22(1):2351. doi: 10.1186/s12889-022-14824-z.
NO ABSTRACT
PMID:36517842 | DOI:10.1186/s12889-022-14824-z
Predicting adverse drug effects: A heterogeneous graph convolution network with a multi-layer perceptron approach
PLoS One. 2022 Dec 14;17(12):e0266435. doi: 10.1371/journal.pone.0266435. eCollection 2022.
NO ABSTRACT
PMID:36516131 | DOI:10.1371/journal.pone.0266435
Efficacy of human C1 esterase inhibitor concentrate for treatment of ACE-inhibitor induced angioedema
Am J Emerg Med. 2022 Dec 5;64:121-128. doi: 10.1016/j.ajem.2022.12.001. Online ahead of print.
NO ABSTRACT
PMID:36516670 | DOI:10.1016/j.ajem.2022.12.001
Protective effect of silymarin on tacrolimus-induced kidney and liver toxicity
BMC Complement Med Ther. 2022 Dec 13;22(1):331. doi: 10.1186/s12906-022-03803-x.
NO ABSTRACT
PMID:36514062 | DOI:10.1186/s12906-022-03803-x
Sjekkpunkthemmerindusert myokarditt
Tidsskr Nor Laegeforen. 2022 Dec 12;142(18). doi: 10.4045/tidsskr.21.0817. Print 2022 Dec 13.
NO ABSTRACT
PMID:36511752 | DOI:10.4045/tidsskr.21.0817
Plain language summary of the VOLTAIRE-CD study in people with moderate-to-severe active Crohn's disease
Immunotherapy. 2022 Dec;14(17):1353-1359. doi: 10.2217/imt-2022-0129. Epub 2022 Dec 13.
NO ABSTRACT
PMID:36511191 | DOI:10.2217/imt-2022-0129
Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital
Indian J Med Res. 2022 Jan;156(1):111-121. doi: 10.4103/ijmr.IJMR_1275_20.
NO ABSTRACT
PMID:36510903 | DOI:10.4103/ijmr.IJMR_1275_20
Pyrotinib for Elderly Patients with Advanced HER2-Positive Breast Cancer
Breast Cancer (Dove Med Press). 2022 Dec 6;14:405-415. doi: 10.2147/BCTT.S383272. eCollection 2022.
NO ABSTRACT
PMID:36510611 | PMC:PMC9739962 | DOI:10.2147/BCTT.S383272
Clinical predictors of efavirenz-based regimen treatment durability: A two-year case-control study of antiretroviral-naïve patients
J Infect Public Health. 2023 Jan;16(1):96-103. doi: 10.1016/j.jiph.2022.12.001. Epub 2022 Dec 7.
NO ABSTRACT
PMID:36508946 | DOI:10.1016/j.jiph.2022.12.001
Testosteron-Therapie mit weniger Nebenwirkungen
MMW Fortschr Med. 2022 Dec;164(21-22):74. doi: 10.1007/s15006-022-2198-8.
NO ABSTRACT
PMID:36510087 | DOI:10.1007/s15006-022-2198-8
Factors associated with reluctancy to acquire COVID-19 vaccination: A cross-sectional study in Shiraz, Iran, 2022
PLoS One. 2022 Dec 12;17(12):e0278967. doi: 10.1371/journal.pone.0278967. eCollection 2022.
NO ABSTRACT
PMID:36508442 | PMC:PMC9744289 | DOI:10.1371/journal.pone.0278967
Effects of Aloe Vera in the Treatment of Oral Ulcers: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Oral Health Prev Dent. 2022 Dec 12;20(1):509-516. doi: 10.3290/j.ohpd.b3666483.
NO ABSTRACT
PMID:36504087 | DOI:10.3290/j.ohpd.b3666483
Pre-incisional infiltration with ropivacaine plus dexamethasone palmitate emulsion for postoperative pain in patients undergoing craniotomy: study protocol for a prospective, randomized controlled trial
Trials. 2022 Dec 12;23(1):996. doi: 10.1186/s13063-022-06936-z.
NO ABSTRACT
PMID:36510271 | DOI:10.1186/s13063-022-06936-z
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma
Front Oncol. 2022 Nov 23;12:1022496. doi: 10.3389/fonc.2022.1022496. eCollection 2022.
NO ABSTRACT
PMID:36505793 | PMC:PMC9727229 | DOI:10.3389/fonc.2022.1022496
Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study
Front Oncol. 2022 Nov 24;12:1046584. doi: 10.3389/fonc.2022.1046584. eCollection 2022.
NO ABSTRACT
PMID:36505772 | PMC:PMC9731103 | DOI:10.3389/fonc.2022.1046584
Efficacy and safety of dorzagliatin for type 2 diabetes mellitus: A meta-analysis and trial sequential analysis
Front Cardiovasc Med. 2022 Nov 23;9:1041044. doi: 10.3389/fcvm.2022.1041044. eCollection 2022.
NO ABSTRACT
PMID:36505359 | PMC:PMC9727304 | DOI:10.3389/fcvm.2022.1041044